Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 1:145:102-113.
doi: 10.1016/j.bcp.2017.08.013. Epub 2017 Aug 19.

Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling

Nour Eissa  1 , Hayam Hussein  2 , Laëtitia Kermarrec  3 , Omar Elgazzar  3 , Marie-Helene Metz-Boutigue  4 , Charles N Bernstein  5 , Jean-Eric Ghia  6
Affiliations

Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling

Nour Eissa et al. Biochem Pharmacol. .

Abstract

Chromogranin-A (CHGA) is a prohormone secreted by neuroendocrine cells and is a precursor of several bioactive peptides, which are implicated in different and distinctive biological and immune functions. Chromofungin (CHR: CHGA47-66) is a short peptide with antimicrobial effects and encodes from CHGA exon-IV. Inflammatory bowel disease (IBD) is characterized by alterations in the activation of pro-inflammatory pathways, pro-inflammatory macrophages (M1), and nuclear transcription factor kappa B (NF-κB) signaling leading to the perpetuation of the inflammatory process. Here, we investigated the activity of CHR (CHGA Exon-IV) in persons with active ulcerative colitis (UC) and the underlying mechanisms in dextran sulfate sodium (DSS)-colitis in regard to macrophages activation and migration. Tissue mRNA expression of CHR (CHGA Exon-IV) was down regulated in active UC compared to healthy individuals and negatively correlated with pro-inflammatory macrophages (M1) cytokines, toll-like receptors (TLR)-4, and pNF-κB activity. In DSS colitis, CHR (CHGA Exon-IV) expression was reduced, and exogenous CHR treatment decreased the severity of colitis associated with a reduction of M1 macrophages markers and pNF-κB. In vitro, CHR treatment reduced macrophages migration, decreased pro-inflammatory cytokines production and pNF-κB. _targeting CHR may represent a promising new direction in research to define new therapeutic _targets and biomarkers associated with IBD.

Keywords: C-Reactive Protein (PubChem CID: 126961377); Chromofungin, CgA(47-66) (PubChem SID: 26684380); Chromogranin-A; Chromogranin-A (PubChem SID: 178101855); Classically activated macrophages (M1); Dextran Sulfate Sodium (PubChem SID: 315501161); Gut hormones; IBD; Interleukin-1β (PubChem CID: 123872); Lipopolysaccharide (PubChem CID: 11970143); Mucosal Drug Action.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Grants and funding

  NODES
INTERN 4
twitter 2